Clinical trial
Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With…
NCT00163319 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00163319 |
|---|---|
| Title | Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101) |
| Official title | Comparison of Inhaled Ciclesonide (640 mcg/Day) and Fluticasone Propionate (1000 mcg/Day) in Patients With Moderate and Severe Persistent Asthma |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Ciclesonide |
| Enrollment | 500 |
| Start date | Nov 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Dec 2, 2016 |
| Countries | Belgium, France, Italy, Netherlands, Spain, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: